Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 11-1999 | 08-1999 | 05-1999 | 02-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,030 | -4,470 | -7,180 | 170 | 9,630 |
| Depreciation Amortization | 117 | 9,890 | 5,700 | 2,170 | 6,190 |
| Other Working Capital | -12 | -11,030 | -4,110 | -3,980 | 8,930 |
| Other Operating Activity | 555 | 4,640 | 5,500 | 30 | -2,890 |
| Operating Cash Flow | $-5,370 | $-970 | $-90 | $-1,610 | $21,860 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -5,650 | -3,770 | -1,590 | -6,940 |
| Net Acquisitions | 0 | -24,870 | -24,870 | 0 | 0 |
| Other Investing Activity | 4,565 | 30,512 | 30,470 | 10,710 | -6,160 |
| Investing Cash Flow | $4,565 | $-8 | $1,830 | $9,120 | $-13,100 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 6,293 | 570 | -4,840 | -200 | -4,330 |
| Financing Cash Flow | $6,293 | $570 | $-4,840 | $-200 | $-4,330 |
| Exchange Rate Effect | 0 | -90 | -30 | -250 | 200 |
| Beginning Cash Position | 3,829 | 19,070 | 19,070 | 19,070 | 14,450 |
| End Cash Position | 9,316 | 18,570 | 15,940 | 26,130 | 19,070 |
| Net Cash Flow | $5,487 | $-500 | $-3,130 | $7,050 | $4,620 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,370 | -970 | -90 | -1,610 | 21,860 |
| Free Cash Flow | -5,370 | -970 | -90 | -1,610 | 21,860 |